Discovery of selective HDAC6 inhibitors capped by flavonoid or flavonoid-analogous moieties as anti-cancer therapeutics simultaneously harboring anti-proliferative and immunomodulatory activities.
Bioorg Chem
; 129: 106146, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-36130439
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Flavonoids
/
Histone Deacetylase Inhibitors
Limits:
Animals
/
Humans
Language:
En
Journal:
Bioorg Chem
Year:
2022
Document type:
Article
Affiliation country:
China